Stanford Libraries Stanford Libraries
Login My Account Feedback
Reporting from:
Check system status

(Stanford users can avoid this Captcha by logging in.)

Cancel

SearchWorks articles+

Home
Select search scope, currently: articles+
  • all catalog, articles, website, & more in one search
  • catalog books, media & more in the Stanford Libraries' collections
  • articles+ journal articles & other e-resources
  • Help
    • Need help?
      • Chat with us (limited to Stanford community)
      • Email a reference question
      • Find a subject specialist
      • Using SearchWorks
    • Connection
      • Connect to e-resources
      • Report a connection problem
    • If we don't have it
      • Interlibrary borrowing
      • Suggest a purchase (limited to Stanford community)
    • System status
  • Connection problem?
  • Selections (0)
    • Clear all lists
Reporting from:
Check system status

(Stanford users can avoid this Captcha by logging in.)

Cancel

Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses

APA

Chang, A., Chiang, T. P., Kim, J. D., Mitchell, J., Alejo, J. L., Jefferis, A. A., Avery, R. K., Tobian, A. A. R., Levan, M. L., Warren, D. S., Garonzik-Wang, J. M., Massie, A. B., Segev, D. L., & Werbel, W. A. (2022). Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses. CLINICAL TRANSPLANTATION, e14738. https://doi.org/10.1111/ctr.14738

CHICAGO

Chang, Amy, Teresa PY. Chiang, Jake D. Kim, Jonathan Mitchell, Jennifer L. Alejo, Alexa A. Jefferis, Robin K. Avery, et al. 2022. “Improved Humoral Immunogenicity with MRNA-1273 versus BNT162b2 as Third Vaccine Dose among Solid Organ Transplant Recipients Seronegative after Two BNT162b2 Doses.” CLINICAL TRANSPLANTATION, June, e14738. doi:10.1111/ctr.14738.

HARVARD

Chang, A. et al. (2022) ‘Improved humoral immunogenicity with mRNA-1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses’, CLINICAL TRANSPLANTATION, p. e14738. doi:10.1111/ctr.14738.

MLA

Chang, Amy, et al. “Improved Humoral Immunogenicity with MRNA-1273 versus BNT162b2 as Third Vaccine Dose among Solid Organ Transplant Recipients Seronegative after Two BNT162b2 Doses.” CLINICAL TRANSPLANTATION, June 2022, p. e14738., https://doi.org/10.1111/ctr.14738.

TURABIAN

Chang, Amy, Teresa PY. Chiang, Jake D. Kim, Jonathan Mitchell, Jennifer L. Alejo, Alexa A. Jefferis, Robin K. Avery, et al. “Improved Humoral Immunogenicity with MRNA-1273 versus BNT162b2 as Third Vaccine Dose among Solid Organ Transplant Recipients Seronegative after Two BNT162b2 Doses.” CLINICAL TRANSPLANTATION, June 14, 2022, e14738. doi:10.1111/ctr.14738.
Stanford Libraries
  • Hours & locations
  • My Account
  • Ask us
  • Opt out of analytics
  • System status
Stanford University
  • Stanford Home
  • Maps & Directions
  • Search Stanford
  • Emergency Info
  • Terms of Use
  • Privacy
  • Copyright
  • Trademarks
  • Non-Discrimination
  • Accessibility

© Stanford University, Stanford, California 94305.